Displaying 576 - 600 of 1558
Source:
Test
Methodology:
Flow Cytometry
Standard Leukemia/Lymphoma Panel - 24 markers
Methodology
Flow Cytometry
Test Description
Available as global and tech-only. Markers are CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD13, CD14, CD16,…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
STAT6
Methodology
Immunohistochemistry (IHC)
Test Description
STAT6 is a highly sensitive and specific immunohistochemical marker for solitary fibrous tumor (SFT) and can be helpful to distinguish…
Source:
Test
Methodology:
Immunohistochemistry (IHC), In Situ Hybridization (ISH), Molecular, Morphologic Evaluation
Surgical Pathology Consultation
Alternative Name
Pathology consults, second opinions, morphology consults
Methodology
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Molecular…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Synaptophysin
Methodology
Immunohistochemistry (IHC)
Test Description
Antibody to synaptophysin reacts with neuroendocrine neoplasms of neural as well as epithelial types. In combination with…
Source:
Test
Methodology:
Flow Cytometry
T-ALL Add-On Flow Panel
Alternative Name
T-Cell Acute Lymphoblastic Leukemia/Lymphoma Add-On Panel
Methodology
Flow Cytometry
Test Description
Available as global and…
Source:
Test
Methodology:
Flow Cytometry
T-ALL Follow-Up Flow Panel
Alternative Name
T-Cell Acute Lymphoblastic Leukemia/Lymphoma Follow-Up Panel
Methodology
Flow Cytometry
Test Description
Available as…
Source:
Test
Methodology:
Molecular
Targeted Solid Tumor NGS Fusion Panel
Alternative Name
Targeted Solid Tumor Fusion Panel
Methodology
Molecular
Test Description
The Targeted Solid Tumor NGS Fusion…
Source:
Test
Methodology:
Flow Cytometry
T&B Tissue Flow Panel
Methodology
Flow Cytometry
Test Description
Stand-alone test. Markers are CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD19, CD20, CD23, CD34, CD38, CD45, CD56, kappa, and…
Source:
Test
Methodology:
Molecular
T-Cell Receptor Beta Gene Rearrangement
Alternative Name
T-Cell Clonality Assessment (Beta)
Methodology
Molecular
Test Description
This test provides qualitative…
Source:
Test
Methodology:
Molecular
T-Cell Receptor Gamma Gene Rearrangement
Alternative Name
T-Cell Gamma Gene Rearrangement, TCRG
Methodology
Molecular
Test Description
Detection of clonal T-cell…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TCL1
Alternative Name
T Cell Leukemia/Lymphoma Protein 1
Methodology
Immunohistochemistry (IHC)
Test Description
T-cell leukemia/lymphoma protein 1 (TCL1) is normally…
Source:
Test
Methodology:
FISH
TCL1 ***
Alternative Name
T-cell leukemia 1
Methodology
FISH
Test Description
Probes: TCL1 (14q32.1)
Disease(s): mature T-cell leukemia, T-cell prolymphocytic leukemia…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TCR Delta
Methodology
Immunohistochemistry (IHC)
Test Description
T-cell receptor delta (TCR delta) is used as a phenotypic marker for TCR delta-expressing T-cells. TCR is a heterodimer composed of…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TCRβF1
Methodology
Immunohistochemistry (IHC)
Test Description
T Cell Receptor beta (TCRβ) is used as a phenotypic marker for TCRβ expressing T-cells. TCRβ is expressed by thymocytes and a majority of…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TdT (Terminal Deoxynucleotidyl Transferase)
Methodology
Immunohistochemistry (IHC)
Test Description
TdT is a highly specific marker for the diagnosis and classification of acute lymphoblastic lymphoma…
Source:
Test
Methodology:
Molecular
TERT Promoter Mutation Analysis
Alternative Name
TERT Promoter Mutation
Methodology
Molecular
Test Description
Bi-directional Sanger sequencing is performed using PCR…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TFE3
Methodology
Immunohistochemistry (IHC)
Test Description
Overexpression of TFE3 is a sensitive and specific marker of Xp11 translocation in renal cell carcinomas. TFE3 is also expressed in…
Source:
Test
Methodology:
FISH
TFE3 Rearrangement
Alternative Name
Transcription factor E3
Methodology
FISH
Test Description
Probe(s): TFE3 (Xp11.2)
Disease(s): Renal cell carcinoma (RCC), alveolar…
Source:
Promo
TGH Cancer Institute Reception
NeoGenomics in collaboration with Tampa General Hospital Cancer Institute would like to cordially…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Thrombomodulin (TM)
Methodology
Immunohistochemistry (IHC)
Test Description
Thrombomodulin (TM) is a plasma membrane-related glycoprotein that has anticoagulant activity. TM antigen is found in…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Thyroglobulin (TGB)
Methodology
Immunohistochemistry (IHC)
Test Description
This antibody labels thyroglobulin (TGB) in follicular epithelial cells of the thyroid and colloid. Thyroglobulin antibody…
Source:
Test
Methodology:
Molecular
Thyroid NGS Fusion Panel
Alternative Name
Thyroid Fusion Panel
Methodology
Molecular
Test Description
The Thyroid NGS Fusion Panel is an RNA-based next-generation…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TIA1
Methodology
Immunohistochemistry (IHC)
Test Description
TIA1 (T-cell intracytoplasmic antigen) monoclonal antibody reacts with a 15 kDa cytoplasmic granule-associated protein, expressed in…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
TLE1
Methodology
Immunohistochemistry (IHC)
Test Description
Expression of the transducing-like receptor (TLE) genes, TLE1, TLE2, TLE3 and TLE4, correlate with immature epithelial cells that are…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Toxoplasma
Methodology
Immunohistochemistry (IHC)
Test Description
Toxoplasma is a crescent shaped sporozoan that lives as an intracellular parasite in various tissues of vertebrates and completes its…